Eagle Pharmaceuticals, Inc. Long-Term Debt, Maturity, Year Two
Eagle Pharmaceuticals, Inc. had Long-Term Debt, Maturity, Year Two of $57.50 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2023-08-09
- 2023-06-30: Long-Term Debt, Maturity, Year Two $57.50M.
- 2023-03-31: Long-Term Debt, Maturity, Year Two $62.50M.
- 2022-12-31: Long-Term Debt, Maturity, Year Two $10.00M.
- 2022-09-30: Long-Term Debt, Maturity, Year Two $12.16M.
| Period end | Long-Term Debt, Maturity, Year Two | Long-Term Debt, Maturity, Year Two as first filed |
|---|---|---|
| 2023-06-30 | $57.50M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $62.50M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $10.00M 10-K · filed 2023-03-23 | |
| 2022-09-30 | $12.16M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $13.06M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-08 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $26.00M 10-K · filed 2021-03-05 | |
| 2020-09-30 | $26.00M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $26.00M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $8.00M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $26.00M 10-K · filed 2021-03-05 | $8.00M 10-K · filed 2020-03-02 |
| 2019-09-30 | $5.00M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $38.75M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $5.00M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $38.75M 10-K · filed 2019-02-28 | |
| 2018-09-30 | $5.00M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $5.00M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $5.00M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $5.00M 10-K · filed 2018-02-26 |